tDCS plus cognitive training to improve thinking in persistent post-concussion syndrome
Official title: Effects of Transcranial Direct Current Stimulation for Enhancing Cognitive Function in Individuals With Persistent Post-Concussion Syndrome: A Pilot fMRI/1H-MRS Study
Run by The Hong Kong Polytechnic University · NCT06376500 · Data updated 2026-11-12
This trial will test whether gentle electrical brain stimulation (tDCS) combined with cognitive training can improve thinking and memory in adults with ongoing post-concussion symptoms from a mild head injury 1–6 years ago.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | The Hong Kong Polytechnic University Academic / other |
| Locations | 1 site (Hung Hom, Kowloon) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | August 2027 |
| Study ends | February 2028 |
| Registry record updated | September 25, 2026 |
| Trial ID | NCT06376500 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with a confirmed mild TBI 1–6 years ago who still have cognitive symptoms and can communicate in Chinese are ideal candidates.
✕Probably not a fit
People with other neurological or psychiatric disorders, implanted devices, pregnancy, recent medical instability, or an inability to undergo MRI or follow the protocol are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The program enrolls adults (≥18) with a confirmed mild traumatic brain injury 1–6 years prior who continue to have cognitive symptoms and can communicate in Chinese. Participants receive repeated sessions of transcranial direct current stimulation (tDCS) paired with a structured cognitive training program delivered in-person. Cognitive performance and brain measures (fMRI and magnetic resonance spectroscopy) are collected before and after the intervention to track changes in cognition, cortical connectivity, and excitatory/inhibitory balance. Key exclusions include other neurological or psychiatric disorders, implanted devices, pregnancy, recent medical instability, and inability to tolerate MRI.
Why it matters
Potential benefit: If successful, this approach could reduce persistent cognitive symptoms and improve daily functioning for people with chronic post-concussion syndrome.
How similar studies have gone: Previous small trials of tDCS with cognitive training after TBI have shown mixed but sometimes promising results, so the approach has pilot support but is not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * being 18 years old or older; * having a history of a mild TBI (less than 30 minutes loss of consciousness) 1-6 years prior to the study; * able to communicate in Chinese. Exclusion Criteria: * being without a confirmed diagnosis from the medical practitioner; * having a history of other neurological and psychiatric disorders, skull defect, recent medical instability (within 3 weeks); * being pregnant; * being medication for a psychiatric condition (e.g., major depression, anxiety, schizophrenia); * with any implanted devices or suffering from real claustrophobia or feel uncomfortable in small, enclosed spaces, like MRI tunnel
Where it's running
-
The Hong Kong Polytechnic University
Hung Hom, Kowloon, Hong Kong Recruiting
Study contacts
- Principal investigator: Yvonne Han, PhD — The Hong Kong Polytechnic University
- Study coordinator: Yvonne Han, PhD
- Email: yvonne.han@polyu.edu.hk
- Phone: +852 2766 7578
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
12-week ETAS® supplement for thinking, mood, sleep, and brain health in older adults
This 12-week test will see if taking 1500 mg ETAS® daily helps thinking, mood, sleep, and brain scan measures in healthy adults aged 60–80 with mild cognitive complaints.
-
GyroStim SMART rotational therapy for post-concussion syndrome
This project will test whether adding GyroStim sensorimotor multi-axis rotational therapy (SMART) helps adults with persistent post-concussion syndrome recover faster and more fully.
-
Non-invasive trigeminal nerve stimulation to improve brain fluid flow and slow cognitive decline
This trial will try mild, non-invasive stimulation of a head nerve (the trigeminal nerve) to see if it improves cerebrospinal fluid flow and waste clearance in adults with recent mild traumatic brain injury and in healthy volunteers.
-
Lecanemab to boost synaptic plasticity in early Alzheimer's disease
This study will test whether lecanemab can preserve synaptic function and slow cognitive decline in amyloid-positive people aged 50–90 with mild cognitive impairment or mild Alzheimer's disease.
-
Low-frequency rTMS to reduce belly pain in diarrhea-predominant IBS
This trial tests whether low-frequency repetitive transcranial magnetic stimulation (rTMS) to a brain region can reduce visceral (belly) pain in adults with IBS-D.
-
Investigating neuromodulation techniques for improving gait in Parkinson's disease
This study is testing different brain stimulation techniques to see if they can help people with Parkinson's disease improve their walking and reduce episodes of freezing while they walk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.